Cribriform-morular thyroid carcinoma
https://doi.org/10.14341/serg12450
Abstract
Along with classic papillary thyroid cancer, there are rare histological variants with special clinical features, and often physicians are not well informed about them. We present a clinical case of 25 years-old female, who was diagnosed with papillary thyroid cancer based on neck ultrasound and fine needle aspiration biopsy followed by thyroidectomy. The histological and immunohistochemical investigation (expression of cytokeratin-19, CD 56, thyroglobulin, β-catenin) were performed and cribriform-morular carcinoma was identified. It’s believed that this type of papillary thyroid cancer in the majority of cases is associated with familial adenomatous polyposis of the colon. This disease with an autosomal dominant type of inheritance is caused by the mutation of the APC suppressor gene and characterized by the presence of multiple adenomatous polyps in the colon with a 100% risk of malignancy and colon cancer. The patient underwent an additional examination with colonoscopy which revealed polyps in all parts of the colon ranging in size from 1 mm to 3.5 cm. We identified mutation in gene APC — p.S1104X and performed a preventive coloproctectomy. The histological examination verified tubular and tubulovillous adenomas with moderate epithelial dysplasia. During 6 years of follow-up of patient, structural and biochemical remission of thyroid cancer was observed.
About the Authors
Timur A. BritvinRussian Federation
MD, PhD
Olga A. Nechaeva
MD, PhD
Mikhail E. Beloshitsky
MD, PhD
Tatiana S. Tamazyan
MD
Ekaterina V. Bondarenko
MD
Larisa E. Gurevch
Russian Federation
MD, PhD, Professor
Dmitry Yu. Semenov
MD, PhD, Professor
References
1. Fujimoto T, Hirokawa M, Ota H, et al. Characteristic sonographic features of cribriform papillary thyroid carcinoma for differentiation from other thyroid nodules. J Med Ultrason. 2015;42(1):83-87. doi: https://doi.org/10.1007/s10396-014-0555-7
2. Lam AK, Saremi N. Cribriform-morular variant of papillary thyroid carcinoma: a distinctive type of thyroid cancer. Endocr Relat Cancer. 2017;24(4):R109-R121. doi: https://doi.org/10.1530/ERC-17-0014
3. Levy RA, Hui VW, Sood R, et al. Cribriform-morular variant of papillary thyroid carcinoma: an indication to screen for occult FAP. Fam Cancer. 2014;13(4):547-551. doi: https://doi.org/10.1007/s10689-014-9732-5
4. Akaishi J, Kondo T, Sugino K, et al. Cribriform-Morular Variant of Papillary Thyroid Carcinoma: Clinical and Pathological Features of 30 Cases. World J Surg. 2018;42(11):3616-3623. doi: https://doi.org/10.1007/s00268-018-4644-4
5. Novelli M. The pathology of hereditary polyposis syndromes. Histopathology. 2015;66(1):78-87. doi: https://doi.org/10.1111/his.12590
6. Syngal S, Brand RE, Church JM, et al. ACG Clinical Guideline: Genetic Testing and Management of Hereditary Gastrointestinal Cancer Syndromes. Am J Gastroenterol. 2015;110(2):223-262. doi: https://doi.org/10.1038/ajg.2014.435
7. Dinarvand P, Davaro EP, Doan JV, et al. Familial Adenomatous Polyposis Syndrome: An Update and Review of Extraintestinal Manifestations. Arch Pathol Lab Med. 2019;143(11):1382-1398. doi: https://doi.org/10.5858/arpa.2018-0570-RA
8. Herraiz M, Barbesino G, Faquin W, et al. Prevalence of Thyroid Cancer in Familial Adenomatous Polyposis Syndrome and the Role of Screening Ultrasound Examinations. Clin Gastroenterol Hepatol. 2007;5(3):367-373. doi: https://doi.org/10.1016/j.cgh.2006.10.019
9. Sada H, Hinoi T, Ueno H, et al. Prevalence of and risk factors for thyroid carcinoma in patients with familial adenomatous polyposis: results of a multicenter study in Japan and a systematic review. Surg Today. 2019;49(1):72-81. doi: https://doi.org/10.1007/s00595-018-1710-3
10. Aydemirli MD, van der Tuin K, Hes FJ, et al. A unique case of two somatic APC mutations in an early onset cribriformmorular variant of papillary thyroid carcinoma and overview of the literature. Fam Cancer. 2020;19(1):15-21. doi: https://doi.org/10.1007/s10689-019-00146-4
11. Hirokawa M, Maekawa M, Kuma S, Miyauchi A. Cribriformmorular variant of papillary thyroid carcinoma-Cytological and immunocytochemical findings of 18 cases. Diagn Cytopathol. 2010;38(12):890-896. doi: https://doi.org/10.1002/dc.21309
12. Cameselle-Teijeiro JM, Peteiro-González D, Caneiro-Gómez J, et al. Cribriform-morular variant of thyroid carcinoma: a neoplasm with distinctive phenotype associated with the activation of the WNT/β-catenin pathway. Mod Pathol. 2018;31(8):1168-1179. doi: https://doi.org/10.1038/s41379-018-0070-2
13. D’Elia G, Caliendo G, Casamassimi A, et al. APC and MUTYH Analysis in FAP Patients: A Novel Mutation in APC Gene and Genotype-Phenotype Correlation. Genes (Basel). 2018;9(7):322. doi: https://doi.org/10.3390/genes9070322
14. Park J, Kim J-W, Park H, et al. Multifocality in a Patient with Cribriform–Morular Variant of Papillary Thyroid Carcinoma Is an Important Clue for the Diagnosis of Familial Adenomatous Polyposis. Thyroid. 2019;29(11):1606-1614. doi: https://doi.org/10.1089/thy.2019.0261
Supplementary files
|
1. Figure 1. Ultrasound image of the right lobe of the thyroid gland in B-mode using color Doppler mapping: A - longitudinal scanning; B - transverse scanning. | |
Subject | ||
Type | Исследовательские инструменты | |
View
(260KB)
|
Indexing metadata ▾ |
|
2. Figure 2. Cribriform-morular variant of papillary thyroid cancer, stained with hematoxylin and eosin: A - multiple nodes (magnification x40); B - perforated, trabecular, solid, microfollicular structures of the tumor (magnification x125); B - morula (indicated by an arrow) surrounded by cribriform and solid structures of the tumor (magnification x250); D - areas of papillary structure in the tumor node (magnification x250). This photo is from the personal archive of I.A. Kazantseva. and E.V. Bondarenko. | |
Subject | ||
Type | Исследовательские инструменты | |
View
(874KB)
|
Indexing metadata ▾ |
|
3. Figure 3. Immunophenotype of cribriform-morular variant of papillary thyroid cancer: A - lack of expression of thyroglobulin in tumor cells and the presence of expression in the tissue of the unchanged thyroid gland surrounding tumor structures (magnification x125); B - intense cytoplasmic expression of cytokeratin-19 (magnification x250); B - nuclear-cytoplasmic expression of β-catenin in tumor cells (magnification x250); D - uneven, focal membrane-cytoplasmic expression of CD56 in the papillary structures of the tumor (magnification x250). This photo is from the personal archive of I.A. Kazantseva. and E.V. Bondarenko. | |
Subject | ||
Type | Исследовательские инструменты | |
View
(974KB)
|
Indexing metadata ▾ |
Review
For citations:
Britvin T.A., Nechaeva O.A., Beloshitsky M.E., Tamazyan T.S., Bondarenko E.V., Gurevch L.E., Semenov D.Yu. Cribriform-morular thyroid carcinoma. Endocrine Surgery. 2020;14(2):4-9. (In Russ.) https://doi.org/10.14341/serg12450

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).